KR20130087639A - 대장암 관련 유전자 ｔｏｍ３４ - Google Patents

대장암 관련 유전자 ｔｏｍ３４ Download PDF

Info

Publication number
KR20130087639A
KR20130087639A KR1020137019800A KR20137019800A KR20130087639A KR 20130087639 A KR20130087639 A KR 20130087639A KR 1020137019800 A KR1020137019800 A KR 1020137019800A KR 20137019800 A KR20137019800 A KR 20137019800A KR 20130087639 A KR20130087639 A KR 20130087639A
Authority
KR
South Korea
Prior art keywords
tom34
cells
gene
sequence
polypeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
KR1020137019800A
Other languages
English (en)
Korean (ko)
Inventor
유스케 나카무라
요이치 후루카와
히데아키 타하라
타쿠야 츠노다
사토시 마츠시마
Original Assignee
온코세라피 사이언스 가부시키가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 온코세라피 사이언스 가부시키가이샤 filed Critical 온코세라피 사이언스 가부시키가이샤
Publication of KR20130087639A publication Critical patent/KR20130087639A/ko
Withdrawn legal-status Critical Current

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57419—Specifically defined cancers of colon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3046—Stomach, Intestines
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Urology & Nephrology (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
KR1020137019800A 2005-07-27 2006-07-21 대장암 관련 유전자 ｔｏｍ３４ Withdrawn KR20130087639A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US70326505P 2005-07-27 2005-07-27
US60/703,265 2005-07-27
PCT/JP2006/314947 WO2007013576A1 (en) 2005-07-27 2006-07-21 Colon cancer related gene tom34

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
KR1020087004601A Division KR101325194B1 (ko) 2005-07-27 2006-07-21 대장암 관련 유전자 ｔｏｍ３４

Publications (1)

Publication Number Publication Date
KR20130087639A true KR20130087639A (ko) 2013-08-06

Family

ID=37499354

Family Applications (2)

Application Number Title Priority Date Filing Date
KR1020137019800A Withdrawn KR20130087639A (ko) 2005-07-27 2006-07-21 대장암 관련 유전자 ｔｏｍ３４
KR1020087004601A Expired - Fee Related KR101325194B1 (ko) 2005-07-27 2006-07-21 대장암 관련 유전자 ｔｏｍ３４

Family Applications After (1)

Application Number Title Priority Date Filing Date
KR1020087004601A Expired - Fee Related KR101325194B1 (ko) 2005-07-27 2006-07-21 대장암 관련 유전자 ｔｏｍ３４

Country Status (18)

Country Link
US (1) US8674059B2 (enExample)
EP (1) EP1910839B1 (enExample)
JP (2) JP5095603B2 (enExample)
KR (2) KR20130087639A (enExample)
CN (1) CN101278196B (enExample)
AU (1) AU2006273192B2 (enExample)
BR (1) BRPI0613970B8 (enExample)
CA (1) CA2616497C (enExample)
CY (1) CY1117839T1 (enExample)
DK (1) DK1910839T3 (enExample)
ES (1) ES2584247T3 (enExample)
HU (1) HUE027330T2 (enExample)
PL (1) PL1910839T3 (enExample)
PT (1) PT1910839T (enExample)
RU (2) RU2449020C2 (enExample)
SG (1) SG163614A1 (enExample)
SI (1) SI1910839T1 (enExample)
WO (1) WO2007013576A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2011140168A (ru) * 2009-03-04 2013-04-10 Онкотерапии Сайенс, Инк. Пептиды vangl1 и содержащие их вакцины
TWI485245B (zh) * 2010-01-25 2015-05-21 Oncotherapy Science Inc 經修飾之ｍｅｌｋ胜肽及含此胜肽之疫苗
WO2012032763A1 (en) * 2010-09-07 2012-03-15 Oncotherapy Science, Inc. Vangl1 peptides and vaccines including the same
MY166516A (en) 2010-12-02 2018-07-05 Oncotherapy Science Inc Tomm34 peptides and vaccines including the same
RU2633503C2 (ru) 2011-10-28 2017-10-12 Онкотерапи Сайенс, Инк. Пептиды торк и содержащие их вакцины
WO2013133405A1 (ja) 2012-03-09 2013-09-12 オンコセラピー・サイエンス株式会社 ペプチドを含む医薬組成物
KR101835939B1 (ko) * 2014-08-26 2018-03-23 연세대학교 산학협력단 Wls 단백질의 특정 모티프를 인지하는 항체 및 이를 포함하는 약제학적 조성물

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4722848A (en) 1982-12-08 1988-02-02 Health Research, Incorporated Method for immunizing animals with synthetically modified vaccinia virus
US5785973A (en) * 1988-02-01 1998-07-28 Praxis Biologics, Inc. Synthetic peptides representing a T-cell epitope as a carrier molecule for conjugate vaccines
JPH04504416A (ja) * 1989-02-17 1992-08-06 コセルコ・ミモトープス・ピィ・ティ・ワイ．エル・ティ・ディ． ペプチドの使用方法と合成方法
US5703055A (en) 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery
US5804566A (en) 1993-08-26 1998-09-08 The Regents Of The University Of California Methods and devices for immunizing a host through administration of naked polynucleotides with encode allergenic peptides
US5679647A (en) 1993-08-26 1997-10-21 The Regents Of The University Of California Methods and devices for immunizing a host against tumor-associated antigens through administration of naked polynucleotides which encode tumor-associated antigenic peptides
US5739118A (en) 1994-04-01 1998-04-14 Apollon, Inc. Compositions and methods for delivery of genetic material
US5736524A (en) 1994-11-14 1998-04-07 Merck & Co.,. Inc. Polynucleotide tuberculosis vaccine
US5922687A (en) 1995-05-04 1999-07-13 Board Of Trustees Of The Leland Stanford Junior University Intracellular delivery of nucleic acids using pressure
EP0841945B1 (en) 1995-08-03 2006-03-08 Rijksuniversiteit te Leiden Cell derived antigen presenting vesicles
US5840839A (en) * 1996-02-09 1998-11-24 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Alternative open reading frame DNA of a normal gene and a novel human cancer antigen encoded therein
US5853719A (en) 1996-04-30 1998-12-29 Duke University Methods for treating cancers and pathogen infections using antigen-presenting cells loaded with RNA
US6294378B1 (en) 1996-07-26 2001-09-25 Sloan-Kettering Institute For Cancer Research Method and reagents for genetic immunization
FR2766205B1 (fr) 1997-07-16 2002-08-30 Inst Nat Sante Rech Med Nouveau procede de sensibilisation de cellules presentatrices d'antigene et nouveaux moyens pour la mise en oeuvre du procede
US7166573B1 (en) * 1999-05-28 2007-01-23 Ludwig Institute For Cancer Research Breast, gastric and prostate cancer associated antigens and uses therefor
WO2001049310A1 (en) 2000-01-03 2001-07-12 Argonex Pharmaceuticals, Inc. C-ski oncogene-derived peptides for prevention, treatment, and diagnosis of cancer
US7700359B2 (en) * 2000-06-02 2010-04-20 Novartis Vaccines And Diagnostics, Inc. Gene products differentially expressed in cancerous cells
US20040181344A1 (en) * 2002-01-29 2004-09-16 Massachusetts Institute Of Technology Systems and methods for providing diagnostic services
AU2003254950A1 (en) * 2002-08-26 2004-03-11 Kirin Beer Kabushiki Kaisha Peptides and drugs containing the same
DE602004015064D1 (de) 2003-01-06 2008-08-28 Wyeth Corp Zusammensetzungen und verfahren zur diagnose und behandlung von kolonkrebs

Also Published As

Publication number Publication date
KR20080040738A (ko) 2008-05-08
SI1910839T1 (sl) 2016-06-30
RU2449020C2 (ru) 2012-04-27
AU2006273192B2 (en) 2011-09-01
BRPI0613970B1 (pt) 2019-10-29
AU2006273192A1 (en) 2007-02-01
CA2616497C (en) 2016-06-07
US20090214571A1 (en) 2009-08-27
CN101278196B (zh) 2013-05-15
EP1910839A1 (en) 2008-04-16
PL1910839T3 (pl) 2016-11-30
CA2616497A1 (en) 2007-02-01
ES2584247T3 (es) 2016-09-26
RU2011127868A (ru) 2013-01-20
BRPI0613970B8 (pt) 2021-05-25
KR101325194B1 (ko) 2013-11-06
PT1910839T (pt) 2016-07-14
JP5095603B2 (ja) 2012-12-12
WO2007013576A1 (en) 2007-02-01
RU2526196C2 (ru) 2014-08-20
JP2009502732A (ja) 2009-01-29
BRPI0613970A2 (pt) 2011-02-22
HUE027330T2 (en) 2016-09-28
EP1910839B1 (en) 2016-04-27
US8674059B2 (en) 2014-03-18
JP2012125248A (ja) 2012-07-05
SG163614A1 (en) 2010-08-30
DK1910839T3 (en) 2016-07-04
CY1117839T1 (el) 2017-05-17
RU2008107318A (ru) 2009-09-10
HK1115193A1 (zh) 2008-11-21
CN101278196A (zh) 2008-10-01

Similar Documents

Publication Publication Date Title
JP2009502115A (ja) 小細胞肺癌の診断方法
JP2007506425A (ja) 肝細胞癌を診断する方法
JP2009502112A (ja) 腎細胞癌を診断および処置するための方法
JP2012125248A (ja) 結腸癌関連遺伝子ｔｏｍ３４
EP1537417A2 (en) Method of diagnosing colon and gastric cancers
JP4614952B2 (ja) 腎細胞癌（ｒｃｃ）の潜在的な新規治療標的としての低酸素誘導タンパク質２（ｈｉｇ２）
JP2009505632A (ja) 膵臓癌関連遺伝子であるｃｓｔ６およびｇａｂｒｐ
CA2500538A1 (en) Method for treating or preventing metastasis of colorectal cancers
EP1907859B1 (en) Genes and polypeptides relating to prostate cancers
JP5109063B2 (ja) 乳癌に関連する遺伝子およびポリペプチド
HK1115193B (en) Colon cancer related gene tom34
MX2008001345A (es) Gen tom34 relacionado con cancer de colon.
JP2009505631A (ja) 癌関連遺伝子ｒａｓｇｅｆ１ａ

Legal Events

Date Code Title Description
A107 Divisional application of patent
PA0104 Divisional application for international application

Comment text: Divisional Application for International Patent

Patent event code: PA01041R01D

Patent event date: 20130725

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20130820

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20130927

Patent event code: PE09021S01D

PC1202 Submission of document of withdrawal before decision of registration

Comment text: [Withdrawal of Procedure relating to Patent, etc.] Withdrawal (Abandonment)

Patent event code: PC12021R01D

Patent event date: 20131029

WITB Written withdrawal of application